Documents
Application Sponsors
ANDA 203006 | MYLAN LABS LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL-28 | 0.05MG;1MG | 0 | NORETHINDRONE AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; NORETHINDRONE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2013-08-05 | |
LABELING; Labeling | SUPPL | 2 | AP | 2022-04-29 | STANDARD |
Submissions Property Types
CDER Filings
MYLAN LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 203006
[companyName] => MYLAN LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"NORETHINDRONE AND ETHINYL ESTRADIOL","activeIngredients":"ETHINYL ESTRADIOL; NORETHINDRONE","strength":"0.05MG;1MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/05\/2013","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2013\\\/203006Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"08\/09\/2017","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2017-08-09
)
)